Medline Industries Recalls Over 193,000 Surgical Packs Due to Sterilization Concerns
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling Universal Ultragard and Shoulder Drape surgical packs because calibration issues in sterilization equipment may have compromised product sterility.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on March 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Medline Industries, LP has initiated a voluntary recall of specific surgical packs after identifying calibration issues with the equipment used for sterilization and packaging. Although the products were processed through validated sterilization cycles, the calibration errors have the potential to negatively impact the sterility assurance level (SAL) of the devices.
Which Products Are Affected
The recall affects a total of 193,157 units distributed worldwide and nationwide across the United States. The following products are included:
- Universal Ultragard Pack (5/CS): Model Number DYNJP1050UG. Affected lot numbers include 72525030011, 72525050004, 72525100025, 72525100068, 72525020012, 72525040038, 72525060015, 72525060041, 72525080004, 72525080039, and dozens of others listed under UDI-DI 10080196573509.
- Shoulder Drape Pouch Pack (10/CS): Model Number DYNJP8401. Affected Lot Number: 72521080034 (UDI-DI: 10080196740710).
What You Should Do
Medline Industries began notifying customers of the recall via letter on January 7, 2026. Healthcare facilities and distributors should immediately check their inventory for the affected model and lot numbers. Affected products should be quarantined and handled according to the instructions provided in the firm's notification letter. For further information, parties may contact Medline Industries, LP at their Northfield, IL headquarters located at 3 Lakes Dr, 60093-2753.
Why This Matters
This recall is significant because surgical packs must maintain a specific sterility assurance level to prevent patient infections during invasive procedures. A failure in the sterilization process calibration poses a potential health risk to patients.
Source
This information is based on an official Class II recall notice from the FDA. Recall Number: Z-1425-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category